Dakota Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Sell |
17,301
-3,302
| -16% | -$228K | 0.03% | 355 |
|
|
2025
Q1 | $1.43M | Sell |
20,603
-3,381
| -14% | -$235K | 0.03% | 309 |
|
|
2024
Q4 | $2.06M | Sell |
23,984
-9,924
| -29% | -$854K | 0.05% | 255 |
|
|
2024
Q3 | $4.04M | Sell |
33,908
-2,955
| -8% | -$352K | 0.09% | 191 |
|
|
2024
Q2 | $5.26M | Sell |
36,863
-910
| -2% | -$130K | 0.12% | 153 |
|
|
2024
Q1 | $4.85M | Buy |
37,773
+14,221
| +60% | +$1.83M | 0.12% | 157 |
|
|
2023
Q4 | $2.44M | Sell |
23,552
-1,231
| -5% | -$127K | 0.09% | 202 |
|
|
2023
Q3 | $2.25M | Buy |
24,783
+1,035
| +4% | +$94.1K | 0.1% | 187 |
|
|
2023
Q2 | $1.92M | Buy |
23,748
+10,380
| +78% | +$840K | 0.09% | 184 |
|
|
2023
Q1 | $1.06M | Buy |
13,368
+254
| +2% | +$20.2K | 0.07% | 224 |
|
|
2022
Q4 | $887K | Buy |
13,114
+88
| +0.7% | +$5.96K | 0.06% | 234 |
|
|
2022
Q3 | $649K | Buy |
13,026
+58
| +0.4% | +$2.89K | 0.05% | 291 |
|
|
2022
Q2 | $722K | Buy |
+12,968
| New | +$722K | 0.07% | 229 |
|